Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.012
Buy
RSI(14)
59.426
Neutral
STOCH(KDJ)(9,3,3)
73.677
Neutral
ATR(14)
0.018
High Vlolatility
CCI(14)
122.718
Buy
Williams %R
38.089
Buy
TRIX(12,20)
1.096
Buy
StochRSI(14)
47.973
Sell
GeneDx Holdings Corp
WGSWWView Detailed Chart
0.090USD
-0.024-21.79%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-21.79%
5 Days
+41.22%
1 Month
+21.76%
6 Months
-62.05%
Year to Date
-43.69%
1 Year
+183.33%
View Detailed Chart
Agency Rating
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Buy
Moving Average
Indicators
Value
Direction
MA5
0.087
Buy
MA10
0.069
Buy
MA20
0.061
Buy
MA50
0.061
Buy
MA100
0.105
Sell
MA200
0.153
Sell
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Ticker SymbolWGSWW
CompanyGeneDx Holdings Corp
CEOMs. Katherine A. Stueland
Websitehttps://sema4.com/
Related Instruments
+0.85%
+0.52%
+0.55%
+2.07%
+0.69%
-5.50%
-2.03%
-1.42%
-1.41%
-2.04%
+1.17%
-0.87%
+1.36%
-3.71%
-2.13%
-0.07%
-4.89%
-0.09%
-2.96%
-0.34%
